株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

婦人科関連の提携条件と契約

Global Gynecology Partnering 2010-2016: Deal trends, players and financials

発行 Current Partnering, a division of Wildwood Ventures Limited 商品コード 250309
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
婦人科関連の提携条件と契約 Global Gynecology Partnering 2010-2016: Deal trends, players and financials
出版日: 2016年09月01日 ページ情報: 英文
概要

当レポートでは、婦人科関連の提携契約について調査分析し、世界の主要な医療企業によって締結された各種契約の動向、主要取引、大規模取引について検証し、セグメント別の契約ディレクトリも含めて、概略以下の構成でお届けいたします。

エグゼクティブサマリー

第1章 イントロダクション

第2章 婦人科関連の契約における動向

  • イントロダクション
  • 長年にわたる婦人科関連の提携
  • 大手製薬会社の婦人科関連の契約活動
  • 婦人科関連の活動をしていない大手製薬会社
  • 婦人科関連の提携:取引タイプ別
  • 婦人科関連の提携:産業部門別
  • 婦人科関連の提携:開発段階別
  • 婦人科関連の提携:技術タイプ別
  • 婦人科関連の提携:婦人科の適応別
  • 婦人科関連の平均取引条件

第3章 主要な婦人科関連の取引

  • イントロダクション
  • 婦人科関連の主要取引:金額別
  • 大手製薬会社が関与している婦人科関連の主要取引

第4章 大手製薬会社の婦人科関連の取引

  • イントロダクション
  • 大手製薬会社の提携取引の利用方法
  • 大手製薬会社の婦人科関連の提携企業プロファイル

第5章 婦人科関連の提携契約ディレクトリ

  • イントロダクション
  • 取引タイプ別
  • 開発段階別
  • 技術タイプ別

第6章 婦人科関連の契約:適応別

  • イントロダクション
  • 取引:治療適応別

第7章 提携情報提供元

  • オンライン提携
  • 提携イベント
  • 契約に関する参考文献

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: CP2211

The ‘Global Gynecology Partnering 2010-2016: Deal trends, players and financials report’ provides comprehensive understanding and unprecedented access to the gynecology partnering deals and agreements entered into by the worlds leading healthcare companies

‘Global Gynecology Partnering 2010-2016: Deal trends, players and financials’ provides the full collection of Gynecology disease deals signed between the world's pharmaceutical and biotechnology companies since 2010.

  • Trends in Gynecology partnering deals
  • Financial deal terms for headline, upfront and royalty by stage of development
  • Gynecology partnering agreement structure
  • Gynecology partnering contract documents
  • Top Gynecology deals by value
  • Most active Gynecology dealmakers

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Gynecology disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Gynecology deals.

The report presents financial deal terms values for Gynecology deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

The initial chapters of this report provide an orientation of Gynecology dealmaking trends.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in Gynecology dealmaking since 2010 covering trends by year, deal type, stage of development, technology type and therapeutic indication.

Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates.

Chapter 4 provides a review of the leading Gynecology deals since 2010. Deals are listed by headline value. The chapter includes the top 25 most active Gynecology dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 5 provides comprehensive access to Gynecology deals since 2010 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive directory of all Gynecology partnering deals by specific Gynecology target announced since 2010. The chapter is organized by specific Gynecology therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

In addition, a comprehensive appendix is provided with each report of all Gynecology partnering deals signed and announced since 2010. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Gynecology partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Gynecology technologies and products.

Report scope

‘Global Gynecology Partnering 2010 to 2016’ is intended to provide the reader with an in-depth understanding and access to Gynecology trends and structure of deals entered into by leading companies worldwide.

‘Global Gynecology Partnering 2010 to 2016’ includes:

  • Trends in Gynecology dealmaking in the biopharma industry since 2010
  • Analysis of Gynecology deal structure
  • Access to headline, upfront, milestone and royalty data
  • Access to hundreds of Gynecology deal contract documents
  • Comprehensive access to over 3500 Gynecology deal records
  • The leading Gynecology deals by value since 2010
  • Most active Gynecology dealmakers since 2010
  • The report includes deals for the following indications: Adenomyosis, Cervical Intraepithelial Neoplasia (CIN), Endometriosis, Fibroids, Human papillomavirus (HPV), Infertility, Menopause, Ovarian failure, Pelvic inflammatory disease, Polycystic ovary syndrome, Pre-menstrual syndrome, Prolapse, Amenorrhea, Dysmenorrhea, Pelvic pai, Vaginitis, plus other gynecological indications.

In ‘Global Gynecology Partnering 2010 to 2016’, available deals and contracts are listed by:

  • Headline value
  • Upfront payment value
  • Royalty rate value
  • Stage of development at signing
  • Deal component type
  • Technology type
  • Specific therapy indication

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The ‘Global Gynecology Partnering 2010-2016’ report provides comprehensive access to available deals and contract documents for over 200 gynecology deals. Analyzing actual contract agreements allows assessment of the following:

  • What are the precise rights granted or optioned?
  • What is actually granted by the agreement to the partner company?
  • What exclusivity is granted?
  • What is the payment structure for the deal?
  • How are the sales and payments audited?
  • What is the deal term?
  • How are the key terms of the agreement defined?
  • How are IPRs handled and owned?
  • Who is responsible for commercialization?
  • Who is responsible for development, supply, and manufacture?
  • How is confidentiality and publication managed?
  • How are disputes to be resolved?
  • Under what conditions can the deal be terminated?
  • What happens when there is a change of ownership?
  • What sublicensing and subcontracting provisions have been agreed?
  • Which boilerplate clauses does the company insist upon?
  • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
  • Which jurisdiction does the company insist upon for agreement law?

Benefits

‘Global Gynecology Partnering 2010-2016: Deal trends, players and financials’ provides the reader with the following key benefits:

  • In-depth understanding of Gynecology deal trends since 2010
  • Access Gynecology deal headline, upfront, milestone and royalty data
  • Research hundreds of actual contracts between Gynecology partner companies
  • Comprehensive access to over 750 links to actual Gynecology deals entered into by the world's biopharma companies
  • Indepth review of Gynecology deals entered into by the top 25 most active dealmakers
  • Benchmark the key deal terms companies have agreed in previous deals
  • Identify key terms under which companies partner Gynecology opportunities
  • Uncover companies actively partnering Gynecology opportunities

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Gynecology dealmaking

  • 2.1. Introduction
  • 2.2. Gynecology partnering over the years
  • 2.3. Gynecology partnering by deal type
  • 2.4. Gynecology partnering by industry sector
  • 2.5. Gynecology partnering by stage of development
  • 2.6. Gynecology partnering by technology type
  • 2.7. Gynecology partnering by therapeutic indication

Chapter 3 -Financial deal terms for Gynecology partnering

  • 3.1. Introduction
  • 3.2. Disclosed financials terms for Gynecology partnering
  • 3.3. Gynecology partnering headline values
  • 3.4. Gynecology deal upfront payments
  • 3.5. Gynecology deal milestone payments
  • 3.6. Gynecology royalty rates

Chapter 4 - Leading Gynecology deals and dealmakers

  • 4.1. Introduction
  • 4.2. Most active in Gynecology partnering
  • 4.3. List of most active dealmakers in Gynecology
  • 4.4. Top Gynecology deals by value

Chapter 5 - Gynecology contract document directory

  • 5.1. Introduction
  • 5.2. Gynecology partnering deals where contract document available

Chapter 6 - Gynecology dealmaking by therapeutic target

  • 6.1. Introduction
  • 6.2. Deals by Gynecology therapeutic target

Appendices

  • Appendix 1 - Directory of Gynecology deals by company A-Z 2010 to 2016
  • Appendix 2 - Directory of Gynecology deals by deal type 2010 to 2016
  • Appendix 3 - Directory of Gynecology deals by stage of development 2010 to 2016
  • Appendix 4 - Directory of Gynecology deals by technology type 2010 to 2016
  • Further reading on dealmaking
  • Deal type definitions

About Wildwood Ventures

  • Current Partnering
  • Current Agreements
  • Recent report titles from CurrentPartnering

Table of figures

  • Figure 1: Gynecology partnering since 2010
  • Figure 2: Gynecology partnering by deal type since 2010
  • Figure 3: Gynecology partnering by industry sector since 2010
  • Figure 4: Gynecology partnering by stage of development since 2010
  • Figure 5: Gynecology partnering by technology type since 2010
  • Figure 6: Gynecology partnering by indication since 2010
  • Figure 7: Gynecology deals with a headline value
  • Figure 8: Gynecology deals with upfront payment values
  • Figure 9: Gynecology deals with milestone payment
  • Figure 10: Gynecology deals with royalty rates
  • Figure 11: Active Gynecology dealmaking activity- 2010 to 2016
  • Figure 12: Top Gynecology deals by value since 2010
Back to Top